Action Potential Venture Capital

Action Potential Venture Capital (APVC) is GSK's bioelectronic medicines venture fund. APVC is focused on the next generation of peripheral neuromodulation medical devices and invests in companies and technologies that enable the future of targeted and adaptive bioelectronics.